학술논문
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial
Document Type
Article
Author
Platzbecker, U.; Della Porta, M.G.; Santini, V.; Zeidan, A.M.; Komrokji, R.S.; Shortt, J.; Valcarcel, D.; Jonasova, A.; Dimicoli-Salazar, S.; Tiong, I.S.; Lin, C.-C.; Li, J.; Zhang, J.; Giuseppi, A.C.; Pozharskaya, V.; Keeperman, K.L.; Rose, S.; Hayati, S.; Vodala, S.; Prebet, T.; Kreitz, S.; Shetty, J.K.; Degulys, A.; Paolini, S.; Cluzeau, T.; Fenaux, P.; Garcia-Manero, G.
Source
In: The Lancet . (The Lancet, 29 July 2023, 402(10399):373-385)
Subject
Language
English
ISSN
1474547X
01406736
01406736